Bupropion/Zonisamide

安非他酮/唑尼沙胺

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBupropion/Zonisamide
Drug Alias NameZonisamide IR/bupropion SR唑尼沙胺/安非他酮Bupropion SR/zonisamide SR安非他酮唑尼沙胺Bupropion and Zonisamide +[12] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersCarbonic anhydrases inhibitorsVoltage-gated calcium channel blockers +[5] 
TargetsCarbonic anhydrasesSodium channel alpha subunitVoltage-gated calcium channel +[5] 
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Bupropion HydrochlorideZonisamide
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrexigen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrexigen Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A